comparemela.com

Latest Breaking News On - Peter fonjungo - Page 1 : comparemela.com

Central African health workers fighting mpox face lack of vaccines and medication

The mpox virus spread globally earlier this year, bringing fears of another pandemic. Many western countries fought off the outbreak with treatments and vaccines. But in the Democratic Republic of the Congo, the virus remains endemic, as it has for decades. Special correspondent Benedict Moran and video journalist Jorgen Samso report.

Monkeypox: DRC research could lead the way in eradicating the disease

WHO - World Health Organization Regional[ ] (via Public) / Africa steps up targeted COVID-19 vaccination of most at risk people

WHO - World Health Organization Regional[ ] (via Public) / Africa steps up targeted COVID-19 vaccination of most at risk people
publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.

Africa Steps Up Targeted COVID-19 Vaccination of Most at Risk People

HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy — Eight Sub-Saharan Africa Countries, 2013–2018

What is already known about this topic? HIV viral load monitoring is recommended to assess antiretroviral treatment success; however, low- and middle-income countries face financial, operational, and country-specific challenges that must be overcome to adequately scale up viral load monitoring for all HIV-positive persons. What is added by this report? Sub-Saharan African countries have overcome challenges to initiate and scale up HIV viral load testing to monitor patients receiving ART. By 2018, seven of eight assessed countries reported viral load suppression rates of ≥85%. Logistical problems remain in several countries. What are the implications for public health practice? Viral load testing in low- and middle-income countries enables monitoring of viral load suppression at the individual and population level, which is necessary to achieve global epidemic control.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.